Recently, spatial omics has become a powerful tool, enabling researchers to see not only what molecules are present in a ...
A long-read RNA sequencing atlas of 144 paired tumor-normal samples across ten organs shows that gene expression changes ...
A large-scale re-annotation of the Aspergillus fumigatus genome reveals that many presumed pathogen-specific genes are ...
Entrada Therapeutics is rated Buy with a $8.50 fair value, offering ~52% upside from $5.61, driven by potential validation of ...
Stanford Medicine researchers and collaborators developed an RNA-based urine test that could improve bladder cancer diagnosis ...
TychoBio will test candidate RNA therapies and use PacBio sequencing to measure how each one changes the transcriptome across multiple cell types. Those results will become training data for models ...
A team of biochemists at the University of Minnesota (UMN) accidentally discovered that a single bacterial DNA repair gene ...
PCR™ with AutoNorm intelligent normalization technology for next‑generation sequencing (NGS) library preparation, today announced new and expanded distribution partnerships that significantly increase ...
TychoBio will test candidate RNA therapies across multiple cell types and use PacBio sequencing to measure changes in the transcriptome following treatment. The resulting data will be used to train ...
Resero Bio, a precision diagnostics company building a cell-free RNA (cfRNA) liquid biopsy platform, today announced ...
Burmese pythons in Florida's Everglades are carrying three previously unknown RNA viruses, raising questions about whether ...
Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results